1 Day PSO 1.23% DJIA -0.25% S&P 500 -0.29% Energy 1.41% ...

No new safety concerns and consistent safety profiles were observed for long-term risankizumab use in patients with psoriasis and PsA.

Improvements in 2 patient-reported outcome measures were observed among patients with psoriasis treated with deucravacitinib vs placebo or apremilast.

If the deal goes through, PSO said the average residential customer using 1,100 kWh per month would see an increase of $7.24 ...

Alumis, a recent IPO, has ESK-001, a promising phase 3 TYK2 inhibitor for Psoriasis and SLE, showing superior efficacy and safety over existing treatments. ESK-001's allosteric inhibition offers high ...

Try your luck during The Price is Right Live at Cross Insurance Arena in Portland on Sept. 25.

Multiple complaints have come to the attention of the Groat regarding the reliability of Eastern Airways flights between Wick ...

PSO sent the proposal to the Oklahoma Corporation Commission earlier this week. Just so we're clear, the Commission must ...

an increase of 805.57 points or 1.01%. Buying was witnessed in some select shares in sectors such as automobile assemblers, ...

The Musical Nature Walk, with musicians from the Peterborough Symphony Orchestra (PSO) and guides from the Peterborough Field Naturalists (PFN), takes place Saturday, Sept. 14 from 1 until 3:30 p.m.

1 Day PSO 0.43% DJIA 1.26% S&P 500 1.70% Energy 0.24% ...

Current Print Subscribers will be prompted to either login to their current site user account or to create a new one. A confirmation email will be sent when a new user account is created, which must ...